segment

Contract Research Organizations

Bringing your drugs and medical devices to market faster

The trend of large pharmaceutical companies divesting parts of their R&D infrastructure for better cost containment, revenue growth, and shorter clinical trial cycles has increased business for Contract Research Organizations (CROs). However, these collaborative partnerships are creating a need for flexible arrangements and integrated end-to-end wellness management solutions. This is particularly true as companies are embracing adaptive study designs that require data visualization, analytics, and transparency across the clinical trial continuum. To be successful, CROs need to align their services to support their customers to efficiently navigate regulatory compliance pathways and shorten the clinical trial lifecycle, all without compromising quality. By adopting unique technology solutions, CROs have the ability to develop reputations as leaders in moving new drugs and devices from conception to FDA/EMA marketing approval with limited sponsor dependence.

Related content